Analysts Are Downgrading These 10 Pharmaceutical Stocks
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
Antares Pharma Inc. (ATRS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ExodusPoint Capital Michael Gelband | 0 | $0 | 0% | |
| 2. | Clearline Capital Marc Majzner | 0 | $0 | 0% | |
| 3. | D E Shaw D. E. Shaw | 0 | $0 | 0% | |
| 4. | AQR Capital Management Cliff Asness | 0 | $0 | 0% | |
| 5. | GLG Partners Noam Gottesman | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.85 | 16,400 | Officer | 646,465 | 2020-11-12 | Filing | |
| $2.79 | 130,000 | Officer | 331,434 | 2017-06-09 | Filing | |
| $2.03 | 100,000 | Officer | 100,000 | 2016-12-09 | Filing | |
| $0.77 | 20,000 | Officer | 20,000 | 2016-03-21 | Filing | |
| $0.72 | 50,000 | Director | 88,172 | 2016-03-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.28 | 50,000 | Director | 224,406 | 2021-03-11 | Filing | |
| $5.00 | 241,960 | Officer, Director | 2,204,760 | 2021-02-18 | Filing | |
| $5.01 | 17,844 | Officer, Director | 2,446,720 | 2021-02-18 | Filing | |
| $5.00 | 232,156 | Officer, Director | 2,464,564 | 2021-02-18 | Filing | |
| $4.75 | 5,519 | Officer, Director | 2,446,720 | 2021-02-17 | Filing |
Institutional Investors' Holdings
News See All
10 Hottest Stocks to Watch on Wednesday
The US stock market is in the green today, with investors absorbing the earnings results of some notable companies.
Were Hedge Funds Right About Antares Pharma Inc (ATRS)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Is ATRS A Good Stock To Buy Now?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Antares Pharma Inc (ATRS): Hedge Funds In Wait-and-See Mode
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Did Hedge Funds Make The Right Call On Antares Pharma Inc (ATRS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been This Bullish On Antares Pharma Inc (ATRS)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Hedge Fund and Insider Trading News: Tom Steyer, Daniel Och, Netflix Inc (NFLX), Antares Pharma Inc (ATRS), and More
CEDAR RAPIDS - California businessman Tom Steyer says he plans to spend at least $100 million on his campaign for the 2020 Democratic presidential nomination.
Here is What Hedge Funds Think About Antares Pharma Inc (NASDAQ:ATRS)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the ...
Hedge Funds Are Selling Antares Pharma Inc (ATRS)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Billionaire Hedge Funds
